Medical Device News

Glooko Collaborates with Johns Hopkins Medicine HealthCare Solutions on Clinically Proven Digital Health Technology for Chronic Conditions

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Glooko, Inc., a leading provider of remote patient monitoring and digital health solutions for diabetes and other chronic conditions, today announced a collaboration with Johns Hopkins HealthCare Solutions.

Glooko’s cloud-based, device-agnostic platform and patient app will provide vitals capture and tracking enablement to the Johns Hopkins Blossom™ program, an interactive management program for people with diabetes, offered through employers, health plans and health care providers.

The Blossom solution provides an interactive experience that combines biometric data tracking, personalized skill-building content, and support from coaches to help people with diabetes better assess, understand, and optimize their care and build a healthier lifestyle. Blossom was developed to make diabetes management easier through lifestyle modifications while significantly improving health outcomes and reducing the cost of care.

Glooko is pleased to work with Johns Hopkins HealthCare Solutions to enable a solution that helps patients, employees and health plan members succeed in making positive lifestyle adjustments and improve connections with their care teams, leading to better health,” said Glooko CEO Russ Johannesson. “Opportunities like the Blossom collaboration further expand Glooko’s value and offerings for our health care provider, payer and employer customers. We look forward to continuing to create real and meaningful differences in the lives of people with chronic conditions like diabetes, while reducing the cost of their care.”

Published research has shown that remote patient monitoring coupled with clinically proven behavior change protocols can improve health outcomes among people with diabetes and reduces costs*.

Glooko’s cloud-based digital health platform and patient app integrate seamlessly into the Blossom solution, meeting patients where they are on their journey to better health. Glooko’s data tracking and sharing allows Blossom coaches and customer care teams to provide continuity of care in between doctors’ appointments–through personalized diabetes education content, care coordination and a 365-day coaching program–by identifying and closing any gaps in patient care. The ability to remotely share data also makes it possible to equip care teams with continual data to identify at-risk patients, intervene as needed, and provide more personalized, informed care.

The solution is available to payers, providers and self-insured employers immediately.


References

  1. Tong Sheng, Linda Parks, Sarine Babikian, Vikram Singh, Mark A. Clements. Immediate and Sustained Trends in Glycemic Control during Remote Patient Monitoring in People with Type 2 Diabetes. ADA Scientific Sessions. June 2021
  2. Tong Sheng, Linda Parks, Sarine Babikian, Vikram Singh, Michael Greenfield, Mark A. Clements Glycemic Improvements Following Mobile-Enabled Remote Patient Monitoring: A Randomized Control Study. ADA Scientific Sessions. June 2020.
  3. Mark A Clements, Janelle Duffee, Dawn McCarther. Remote patient monitoring for adults with type 2 diabetes. ADCES Research Sessions. August 2020.
  4. Maureen J. Lage & Kristina S. Boye (2020) The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database, Current Medical Research and Opinion, 36:9, 1441-1447, DOI: 10.1080/03007995.2020.1787971
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

Ann Decker, VP of Reimbursement for Valencia Technologies, stated, "The cumulative effect of the proposed 2025 continuation of APC assignment 5464, the improved ASC payment rate, and the recognition of ITNS as a minimally invasive OAB treatment option in the recently updated guidelines by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU), underscores that the eCoin ITNS system will have a strong reimbursement pathway throughout 2025 and beyond.